Strategy of continuous intake of vitamin K antagonists in the perioperative period of radiofrequency catheter ablation of atrial fibrillation
Keywords:
atrial fibrillation, anticoagulation, catheter ablation
Abstract
The article analyzes first-hand experience of anticoagulation therapy in the perioperative period of catheter ablation of atrial fibrillation (AF). The group under study included 39 patients, who underwent 40 AF catheter ablations. For systemic anticoagulation all patients were taking vitamin K antagonists (with 37 patients taking Warfarin, one patient – Fenilin, and one – Sinkumar). Each patient was undergoing catheter ablation, with anticoagulant being taken continuously.
References
1. Scherr D., Sharma K., Dalal D., et al. Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation // J Cardiovasc Electrophysiol. – Dec. 2009. – Vol. 20 (12). – P. 1357–1363.
2. Calkins et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design // Heart Rhythm. – April 2012. – Vol. 9, No 4. – Р. 632–696.
3. Hakalahti A., Uusimaa P., Ylitalo K., Raatikainen M. J. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment // Europace. – May 2011. – Vol. 13 (5). – P. 640–645.
4. Oussama M. Wazni, MD; Salwa Beheiry, RN; Tamer Fahmy, MD et al. Atrial Fibrillation Ablation in Patients With Therapeutic International Normalized Ratio Comparison of Strategies of Anticoagulation Management in the Periprocedural Period // Circulation. – 2007. – Vol. 116. – P. 2531–2534.
5. Lip G. Y. Does atrial fibrillation confer a hypercoagulable state? // Lancet. – 1995. – Vol. 346. – P. 1313–1314.
6. Kwak J. J., Pak H. N., Jang J. K., et al. Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation // J Cardiovasc Electrophysiol. – Jun 2010. – Vol. 21 (6). – P. 620–625.
7. Hussein A. A., Martin D. O., Saliba W., et al. Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy // Heart Rhythm. – Oct 2009. – Vol. 6 (10). – P. 1425–1429.
8. Schmidt M., Segerson N. M., Marschang H., et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratios // Pacing Clin Electrophysiol. – Aug 2009. – Vol. 32 (8). – P. 995–999.
9. Santangeli P., Di BiaseL., Horton R. et al. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications:evidence from a meta-analysis // CircArrhythmElectrophysiol. – 2012. – Vol. 5. – P. 302–11.
2. Calkins et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design // Heart Rhythm. – April 2012. – Vol. 9, No 4. – Р. 632–696.
3. Hakalahti A., Uusimaa P., Ylitalo K., Raatikainen M. J. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment // Europace. – May 2011. – Vol. 13 (5). – P. 640–645.
4. Oussama M. Wazni, MD; Salwa Beheiry, RN; Tamer Fahmy, MD et al. Atrial Fibrillation Ablation in Patients With Therapeutic International Normalized Ratio Comparison of Strategies of Anticoagulation Management in the Periprocedural Period // Circulation. – 2007. – Vol. 116. – P. 2531–2534.
5. Lip G. Y. Does atrial fibrillation confer a hypercoagulable state? // Lancet. – 1995. – Vol. 346. – P. 1313–1314.
6. Kwak J. J., Pak H. N., Jang J. K., et al. Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation // J Cardiovasc Electrophysiol. – Jun 2010. – Vol. 21 (6). – P. 620–625.
7. Hussein A. A., Martin D. O., Saliba W., et al. Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy // Heart Rhythm. – Oct 2009. – Vol. 6 (10). – P. 1425–1429.
8. Schmidt M., Segerson N. M., Marschang H., et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratios // Pacing Clin Electrophysiol. – Aug 2009. – Vol. 32 (8). – P. 995–999.
9. Santangeli P., Di BiaseL., Horton R. et al. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications:evidence from a meta-analysis // CircArrhythmElectrophysiol. – 2012. – Vol. 5. – P. 302–11.
Published
2016-12-02
How to Cite
Suslina, Y., Meshkova, M., Doronin, A., & Rudenko, N. (2016). Strategy of continuous intake of vitamin K antagonists in the perioperative period of radiofrequency catheter ablation of atrial fibrillation. Ukrainian Journal of Cardiovascular Surgery, (3 (26), 100-102. Retrieved from https://cvs.org.ua/index.php/ujcvs/article/view/214
Section
HEART RHYTHM DISORDER
